Regulatory Roundup: European Medicines Agency Issues Drug Review Update; And More.

Article

ePT--the Electronic Newsletter of Pharmaceutical Technology

European Medicines Agency Issues Drug Review Update; And More

The European Medicines Agency's Committee for Medical Products for Human Use issued an update on drug reviews by the agency on July 23, 2010. Included in the update is information on Avandia (rosiglitazone), generic drugs, pediatric indications, rotavirus vaccines, and more.

The US Food and Drug Administration issued a warning regarding certain Advair Diskus inhalers that were stolen from a distribution warehouse in 2009 and now have been found in some pharmacies. The safety and effectiveness of the stolen inhalers cannot be guaranteed and the inhalers should not be used, said the agency in its announcement.

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes